Patients eligible for proprotein convertase subtilisin/kexin type9 inhibitors (pcsk9i) after acute myocardial infarction. The ESC position applied to patients included in the FAST-MI 2015 registry

31 August 2019 (14:50 - 15:00)
Organised by:
Add to my library
Congress Presentation Part of: Translational research in acute coronary syndrome registries Prevention ESC Premium Access ESC Congress 2019